日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial

甲氨蝶呤联合桥接糖皮质激素治疗早期类风湿关节炎(RA)的疗效,以及早期引入6个月依那西普疗程与否的影响:一项为期2年的实用性随机CareRA2020试验的结果

Bertrand, Delphine; Joly, Johan; Neerinckx, Barbara; Durez, Patrick; Lenaerts, Jan; Joos, Rik; Thevissen, Kristof; Zwaenepoel, Tom; Vanhoof, Johan; Di Romana, Silvana; Taelman, Veerle; Van Essche, Els; Corluy, Luk; Ribbens, Clio; Vanden Berghe, Marc; Devinck, Mieke; Ajeganova, Sofia; Durnez, Anne; Boutsen, Yves; Margaux, Joëlle; Peene, Isabelle; Van Offel, Jan; Doumen, Michaël; Pazmino, Sofia; De Meyst, Elias; Kulyk, Myroslava; Creten, Nelly; Westhovens, René; Verschueren, Patrick

The yeast protein kinase Sch9 adjusts V-ATPase assembly/disassembly to control pH homeostasis and longevity in response to glucose availability

酵母蛋白激酶 Sch9 调节 V-ATPase 组装/拆卸,以控制 pH 稳态和寿命,以响应葡萄糖的可用性

Tobias Wilms, Erwin Swinnen, Elja Eskes, Laura Dolz-Edo, Alice Uwineza, Ruben Van Essche, Joëlle Rosseels, Piotr Zabrocki, Elisabetta Cameroni, Vanessa Franssens, Claudio De Virgilio, Gertien J Smits, Joris Winderickx

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

对于缺乏传统不良预后指标的早期类风湿关节炎患者,采用阶梯式糖皮质激素桥接治疗方案也可能获益:来自随机多中心CareRA试验的第16周结果

Verschueren, Patrick; De Cock, Diederik; Corluy, Luk; Joos, Rik; Langenaken, Christine; Taelman, Veerle; Raeman, Frank; Ravelingien, Isabelle; Vandevyvere, Klaas; Lenaerts, Jan; Geens, Elke; Geusens, Piet; Vanhoof, Johan; Durnez, Anne; Remans, Jan; Vander Cruyssen, Bert; Van Essche, Els; Sileghem, An; De Brabanter, Griet; Joly, Johan; Van der Elst, Kristien; Meyfroidt, Sabrina; Westhovens, Rene